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Introduction
Dynamic reorganization of the actin cytoskeleton is indispens-
able for polarized cellular processes such as cell motility and 
asymmetric cell division. The de novo formation of actin fila-
ments is a crucial step in these events. As such, cells require a 
variety of actin nucleators that are harnessed to the assembly of 
different actin structures (Chesarone and Goode, 2009). Fur-
ther, the proper formation of actin structures underlying cell 
motility, cell polarization, and cytokinesis depends on closely 
coordinated interplay between the actin and microtubule cyto-
skeletons (Drubin and Nelson, 1996; Li and Gundersen, 2008).
Adenomatous  polyposis  coli  (APC),  a  large  350-kD   
multidomain protein (Fig. 1 A), is a tumor suppressor linked   
to colorectal cancer and has an established role in regulating 
microtubule cytoskeleton organization and dynamics (McCartney 
and Näthke, 2008). In addition, APC has been suggested to in-
fluence actin cytoskeleton regulation, but the underlying mech-
anism has been unclear. Previous studies have shown that the 
C-terminal “Basic” region of APC (Fig. 1 A) binds to micro-
tubules and stabilizes microtubules in cells together with its   
binding partner EB1 (Munemitsu et al., 1994; Su et al., 1995; 
Kita et al., 2006). Loss of the C terminus of APC also causes 
defects  in  directional  cell  migration,  a  process  that  requires 
close  coordination  between  the  microtubule  and  actin  cyto-
skeletons (Oshima et al., 1997). To date, the possible direct effects 
of APC on actin dynamics have not been well explored, and it 
has been postulated that the primary influence of APC on actin 
cytoskeleton remodeling occurs through indirect mechanisms, 
mediated by APC interactions with its binding partners, includ-
ing its N-terminal associations with IQGAP and ASEF (Kawasaki 
et al., 2000; Watanabe et al., 2004) and its C-terminal associa-
tions with the formin mDia (Wen et al., 2004). However,   
recently it was shown that the C-terminal Basic domain of APC 
binds directly to F-actin (Moseley et al., 2007).
Here, we demonstrate that the APC-Basic domain induces 
actin assembly in vivo and potently nucleates actin polymeriza-
tion in vitro, providing a direct mechanism for APC in regulat-
ing actin-based cell protrusion, motility, and polarity.
T
he tumor suppressor protein adenomatous poly­
posis coli (APC) regulates cell protrusion and cell 
migration,  processes  that  require  the  coordinated 
regulation  of  actin  and  microtubule  dynamics.  APC   
localizes in vivo to microtubule plus ends and actin­rich 
cortical  protrusions,  and  has  well­documented  direct   
effects on microtubule dynamics. However, its potential   
effects on actin dynamics have remained elusive. Here, 
we show that the C­terminal “basic” domain of APC (APC­B)   
potently nucleates the formation of actin filaments in vitro 
and  stimulates  actin  assembly  in  cells.  Nucleation  is 
achieved by a mechanism involving APC­B dimerization 
and recruitment of multiple actin monomers. Further, APC­B   
nucleation activity is synergistic with its in vivo binding 
partner, the formin mDia1. Together, APC­B and mDia1 
overcome  a  dual  cellular  barrier  to  actin  assembly   
imposed by profilin and capping protein. These observa­
tions  define  a  new  function  for  APC  and  support  an 
emerging  view  of  collaboration  between  distinct  actin   
assembly–promoting factors with complementary activities.
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intermediates,  actin  dimers  and  trimers  (Pring  et  al.,  2003). 
Spire, Cobl, Lmod, and JMY contain WH2 domains and recruit 
actin monomers to form prenucleation complexes that “seed” 
polymerization (Quinlan et al., 2005; Ahuja et al., 2007; Chereau 
et al., 2008; Zuchero et al., 2009). Our data above suggest that 
APC-B uses a mechanism distinct from Arp2/3 complex because 
APC-B  promotes  unbranched  nucleation,  and  distinct  from 
formins because APC-B does not protect barbed end growth 
from capping proteins or accelerate elongation. Therefore, we 
explored whether APC-B recruits actin monomers.
In native PAGE assays, G-actin alone migrated toward the 
anode, whereas APC-B alone migrated toward the cathode con-
sistent with its high content of basic residues (pI = 10.4; Fig. 2 E). 
In the presence of APC-B, G-actin migration was reversed, co-
migrating with APC-B toward the cathode and increasing the 
density of the gel band (Fig. 2 E, bottom). Reactions contained 
100 mM KCl, as well as latrunculin B, which blocks actin poly-
merization. These data suggest that APC-B physically associates 
with G-actin. Second, we tested APC-B–actin interactions by 
sedimentation velocity analysis in the presence of latrunculin B. 
Both APC-B and G-actin migration patterns shifted when mixed 
together compared with the migration patterns of each protein 
alone (Fig. S2, B and C), providing further support for their   
association. Third, we tested APC-B binding to actin monomers 
based on its ability to increase the fluorescence signal of pyrene-
labeled G-actin (0.1 µM) under nonpolymerizing conditions   
including the presence of latrunculin B (Fig. 2 F). Binding was 
concentration dependent and saturated almost precisely at a 1:2 
molar ratio of APC-B to G-actin (Fig. 2 F, dotted line) and with 
an apparent dissociation constant of 17.3 nM. Further addition 
of 5 µM profilin did not alter the effects of 50 nM APC-B on the 
fluorescence of 100 nM pyrene–G-actin (Fig. 2 G). This suggests 
that either APC-B and profilin have nonoverlapping binding sites 
on G-actin or APC-B very efficiently outcompetes profilin for 
G-actin binding, explaining why APC-B nucleation activity is 
not suppressed by the presence of profilin.
To further dissect the nucleation activity of APC, we gen-
erated a series of N- and C-terminally truncated APC-B poly-
peptides and compared their abilities to stimulate actin assembly 
and to bind G-actin (Fig. 3 A; Fig. S3, A–C). This analysis iden-
tified two sequences in APC-B that are critical for nucleation   
in vitro, ANS1 (residues 2326–2353) and ANS2 (residues 2526–
2612). Moreover, constructs N4 and N5, which both delete 
ANS1, drastically reduced APC-B–induced actin assembly in vivo 
(Fig. 3, B and C), suggesting that the ability of APC-B to pro-
mote actin assembly in vivo stems from its nucleation activity. 
Importantly, the truncations did not significantly alter the net 
charge of the APC-B polypeptides (listed in Fig. 3 A), indicating 
that nucleation effects are not due to nonspecific electrostatic 
attractions between APC-B and actin. The specificity of the   
nucleation effects was further demonstrated by the observation 
that ANS2 is not required for APC-B binding to microtubules 
(Fig. 3 A and Fig. S3 D).
We next tested the importance of ANS1 and ANS2 for 
APC-B binding to G-actin by comparing the effects of APC-B, 
N4, and C2 in both the pyrene-actin fluorescence and native 
PAGE assays. In both assays, ANS1 was critical for APC-B 
Results and discussion
APC stimulates actin assembly in vivo  
and in vitro
To investigate effects of the C-terminal Basic (B) region of   
APC on cellular actin dynamics, we introduced a plasmid for 
expression of GFP-APC-B into serum-starved NIH3T3 cells   
by microinjection (Fig. 1 B). GFP-APC-B induced formation   
of bright-staining F-actin structures, and colocalized with them 
(Fig. 1 B). Quantification of the effects showed that GFP-APC-B 
caused a 40% increase in total cellular F-actin content com-
pared with cells injected with empty vector (Fig. 1 C). Further, 
when adjacent cells were microinjected, we observed a marked 
accumulation of F-actin at cell–cell contacts (Fig. 1 B, linescan). 
These observations suggested that APC-B might directly or in-
directly induce actin filament assembly.
To investigate the mechanistic basis of these observations, 
we purified APC-B and a longer polypeptide (APC-C; Fig. 1 A) 
and tested their effects on actin assembly in vitro. Both polypep-
tides accelerated actin assembly in a concentration-dependent 
manner, with potent effects at low nanomolar concentrations 
(Fig. 1 D, APC-C; Fig. S2 A). Electron microscopy and total   
internal reflection fluorescence (TIRF) microscopy analysis of 
samples from early time points in the reactions showed that 
APC-B and APC-C induce formation of unbranched filaments 
(Fig. 1, E and F). APC-B did not sever filaments to promote dis-
assembly (Fig. 1 G) or cap the growing barbed ends (Fig. 1 I) of 
preformed filaments to inhibit growth, demonstrating that the 
ability of APC-B to promote actin assembly does not stem from 
severing or capping. Further, APC-B–induced actin assembly 
was blocked by the barbed end-capping agent cytochalasin D 
(Fig. 1 H). Together, these data show that APC-B promotes   
robust de novo formation of actin filaments that grow primarily 
from their barbed ends.
Next, we directly compared the nucleation activities of 
APC-B and the FH1-FH2 domain-containing C-terminal half   
of mouse formin mDia1 (C-mDia1) at different actin concen-
trations (Fig. 2 A). Interestingly, APC-B was a more effective   
nucleator than C-mDia1 at low actin concentrations, which 
could be an important property in vivo under conditions where 
free actin monomers are limiting. Although formin-induced   
actin nucleation was partially suppressed in the presence of   
profilin, APC-B–induced nucleation was not (Fig. 2, B and C). 
Analysis of filament barbed end elongation rates in the presence 
of profilin by TIRF microscopy further revealed that, unlike 
formins, APC-B did not accelerate elongation (Fig. 2 D and 
Videos 1–3). These results are consistent with APC lacking rec-
ognizable profilin-binding motifs (Fig. S1), and highlight some 
of the major differences between APC-B and formins as actin 
assembly-promoting factors.
APC mechanism of actin nucleation
All nucleators identified to date use one of three mechanisms to 
promote de novo formation of actin filaments (Chesarone and 
Goode, 2009). Arp2/3 complex is proposed to structurally 
mimic the barbed end of an actin filament (Kelleher et al., 1995). 
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Figure 1.  APC directly nucleates actin assembly. (A) Schematic of APC, and Coomassie-stained gel of purified APC polypeptides. (B) GFP fluorescence 
and rhodamine-phalloidin staining of serum-starved NIH3T3 cells. Arrowheads, cells microinjected with EGFP-APC-B plasmid. Arrow, F-actin accumulation 
at cell–cell junction. Bar, 10 µm. Right panel shows linescan quantification of F-actin at cell–cell junctions in the absence (b, red line) or presence (d, red 
line) of GFP-APC-B. (C) Quantification of F-actin levels in cells (n > 50 cells). (D) Assembly of actin (2 µM; 5% pyrene labeled) induced by 0–200 nM APC-B. 
(E) Electron micrographs of actin polymerized for 30 s in the presence or absence of 50 nM APC-C. Bar, 100 nm. (F) TIRF microscopy of actin (1 µM; 
30% labeled) assembled in the presence and absence of 2 nM APC-B, visualized 2–3 min after initiation of polymerization. Bar, 5 µm. (G) Severing and 
depolymerization of 2 µM preformed actin filaments was induced by Cof1 but not APC-B upon addition of 3 µM Vitamin-D binding protein (a monomer 
sequestering factor) to induce depolymerization. (H) 100 nM cytochalasin D blocks the assembly of actin (2 µM) stimulated by 20 nM APC-B. (I) APC-B 
does not protect filament barbed ends against 100 nM CapZ (CP) in seeded filament elongation assay.JCB • VOLUME 189 • NUMBER 7 • 2010   1090
One major class of actin nucleators, which includes Spire, 
Cobl, Lmod, and JMY, contains tandem actin monomer-binding 
domains (typically WH2 domains) used to recruit up to four   
actin monomers into prenucleation complexes (Quinlan et al., 
2005; Ahuja et al., 2007; Chereau et al., 2008; Zuchero et al., 
2009). In Spire and Cobl, two WH2 domains are sufficient for 
weak nucleation, but all four are required for strong activity. 
Our stoichiometry data indicate that each APC-B molecule 
binds two actin monomers (Fig. 2 F). This prompted us to test 
binding to G-actin (Fig. S3, B, C, and E). On the other hand,   
deletion of ANS2 had no effect on APC-B binding to G-actin in 
pyrene fluorescence assays, yet disrupted formation of stable 
APC-B–actin complexes in native PAGE assays. Importantly, 
C2 (which lacks ANS2) had the same 2:1 stoichiometry of 
APC-B–actin binding. These data suggest that ANS1 is crucial 
for actin binding, whereas ANS2 makes a distinct mechanistic 
contribution to formation of stable APC-B–actin complexes 
(see dimerization evidence below).
Figure 2.  Properties of APC as an actin assembly–promoting factor. (A) Comparison of nucleation effects for 20 nM APC-B and 20 nM C-mDia1 at differ-
ent concentrations of actin monomers (5% pyrene labeled). (B and C) Effects of 2 nM C-mDia1 or 20 nM APC-B on the assembly of actin (2 µM; 5% pyrene 
labeled) in the presence or absence of 3 µM profilin. (D) Increase in barbed end elongation rate of individual actin filaments by C-mDia1 and profilin but 
not by APC-B. Rates of elongation were measured in real time by TIRF microscopy and averaged for >10 filaments. Error bars, standard deviation. (E) Na-
tive PAGE assay for APC-B binding to G-actin. Reactions were loaded on gels and run toward either the cathode (top) or anode (bottom), then gels were 
Coomassie stained. (F) Fluorescence-based assay for concentration-dependent binding of APC-B (0–75 nM) to G-actin (100 nM; 100% pyrene labeled). 
Dashed line indicates binding saturation at a 1:2 molar ratio of APC-B to actin. Error bars, standard deviation (n = 3). (G) 5 µM profilin does not affect the 
ability of 50 nM APC-B to increase the fluorescence of pyrene–G-actin (0.1 µM, 100% labeled). Error bars, standard deviation (n = 3).1091 APC protein nucleates actin assembly • Okada et al.
Figure 3.  Dissection of APC-B actin nucleation activity and mechanism. (A) Schematic of APC-B truncated polypeptides analyzed. The actin nucleation 
sequences identified (ANS1 and ANS2) are shaded blue. MTBS, microtubule binding site; N/A, not applicable; N/D, not determined. (B) Deletion of 
ANS1 diminishes the actin nucleation activity of APC-B in cells. Serum-starved NIH3T3 cells microinjected with EGFP-APC-B, EGFP-APC-B-N4, or EGFP-
APC-B-N5 plasmids (arrows) were fixed and imaged for GFP fluorescence and rhodamine-phalloidin staining. Bar, 10 µm. (C) Quantification of total 
cellular F-actin levels (n > 50 cells). (D) Dimerization of APC-C polypeptide. Stokes radius and sedimentation coefficient were determined for MBP–APC-C 
and used to calculate its native molecular weight (MW). Predicted MW of monomer and dimer for MBP–APC-C are listed for comparison. (E) Dominant-
negative effects of truncated APC-B polypeptides on wild-type APC-B–induced actin assembly. Reactions contain actin (2 µM; 5% pyrene labeled) and   
50 nM wild-type APC-B, with or without 50 nM APC-B–N4 (top) or 50 nM APC-B–C2 (bottom).JCB • VOLUME 189 • NUMBER 7 • 2010   1092
Conclusions
Including APC, seven bona fide actin nucleators have now been 
identified, each with unique properties and mechanisms. The 
properties of APC-B as a nucleator are that it: (1) assembles un-
branched filaments; (2) does not require a cofactor, whereas 
Arp2/3 complex does; (3) dimerizes and requires two functional 
halves (separate molecules) for nucleation; (4) fails to protect 
barbed ends of filaments from capping protein; (5) nucleates   
efficiently from profilin–actin; and (6) nucleates by recruiting 
up to four actin monomers, but does not contain recognizable 
WH2 sequences. Thus, APC appears to share at least some 
properties with nucleators of the Spir/Cobl/Lmod/JMY class, 
but also exhibits unique properties (most notably, it dimerizes 
and has no WH2 domains), suggesting that overall it has a novel 
mechanism of nucleation.
Because APC is well established as a microtubule regulator 
and binds to microtubules via its Basic region (Munemitsu et al., 
1994), it was interesting to learn that the Basic region also nucle-
ates actin assembly. Our truncation analysis showed that ANS2 
is required for actin nucleation, and possibly dimerization, but not 
for microtubule binding (Fig. S3 D). Our data also indicate a close 
proximity and partial overlap of the microtubule-binding region 
of APC-B with ANS1; thus, steric hindrance could explain why 
APC-B interactions with actin and microtubules are mutually ex-
clusive (Moseley et al., 2007). In addition, these observations raise 
the question of how APC interactions with actin and microtubules 
are differentially regulated in vivo and/or constrained to specific 
cellular compartments. This could involve post-translational modi-
fications of APC and/or specific binding partners.
Our data also point to a strong synergy between APC-B 
and mDia1 in promoting actin assembly in the combined pres-
ence of profilin and capping protein in vitro and in cells (Fig. 4). 
This offers a functional explanation for the interactions between 
APC and mDia (Wen et al., 2004), although in the absence of 
more detailed information about their association, it is unclear 
whether synergy requires direct APC–mDia interactions. None-
theless, this highlights how cells may combine two different actin 
assembly–promoting factors with unique strengths to bypass 
common inhibitors of nucleation and elongation. This synergy 
between APC-B and mDia1 could occur in vivo at actin-rich 
zones of membrane protrusion and cell–cell contact, where both 
APC and mDia1 have been localized (Watanabe et al., 1997; 
Rosin-Arbesfeld et al., 2001; Carramusa et al., 2007). Such a 
mechanism would offer increased spatiotemporal control over 
actin assembly in vivo, restricting new growth to locations 
where two separate factors had been successfully recruited and 
activated. This strategy may also extend to other pairs of actin 
assembly–promoting factors that have been shown to physically 
interact (e.g., Spire and formins, JMY, and Arp2/3 complex), 
and for which mounting genetic and biochemical evidence   
supports functional synergy (Bosch et al., 2007; Quinlan et al., 
2007; Zuchero et al., 2009).
Finally, our results may have possible implications for 
how truncations in APC lead to colorectal tumor formation. 
Cancer-causing mutations in APC delete the entire C terminus, 
including the Basic domain. This stabilizes -catenin, which is 
sufficient to induce tumor formation, but it has also been suggested 
whether APC-B might dimerize to increase its actin-recruiting 
capacity. Previous studies have shown that the N terminus of 
APC dimerizes (Joslyn et al., 1993), but the properties of the   
C terminus have remained uncharacterized. Therefore, we deter-
mined the Stokes radii and sedimentation coefficients for   
APC-C and from these data calculated its native MW (Fig. 3 D), 
which suggested that APC-C forms a stable and extended dimer. 
A similar hydrodynamic analysis of truncation mutants showed 
that loss of ANS1 (N4) did not affect dimerization (multimer-
ization state of 1.97), whereas loss of ANS2 (C2) weakened 
dimerization (multimerization state of 1.49). Further, N4 domi-
nantly interfered with the actin nucleation activity of wild-type 
APC-B, whereas C2 did not (Fig. 3 E). The simplest interpre-
tation of these results is that N4, which fails to bind actin, may 
interact with wild-type APC-B to form nucleation-incompetent 
heterodimers, whereas C2 is dimerization impaired and there-
fore does not interfere with wild-type APC-B activity. Given the 
2:1 binding stoichiometry of actin to APC-B, we propose that 
each APC-B dimer can recruit up to four actin monomers in a 
prenucleation complex.
Synergy between APC-B and mDia1 in 
assembling actin filaments
We  next  explored  the  functional  relationship  of APC-B  and 
mDia1 in actin assembly. As mentioned above, APC-B nucle-
ates actin assembly efficiently in the presence of profilin, whereas 
C-mDia1 does not (Fig. 2, B and C). On the other hand, C-mDia1 
protects growing barbed ends of filaments from capping pro-
teins, whereas APC-B does not (Fig. 1 H). Given these comple-
mentary activities, and their reported physical interactions (Wen 
et al., 2004), we tested the combined effects of APC-B and   
C-mDia1 on actin assembly in the presence of profilin and cap-
ping protein, which presents a double barrier to actin assembly 
reflective of in vivo conditions (Fig. 4 A). APC-B alone and   
C-mDia1 alone showed only a weak ability to stimulate actin 
assembly under these conditions. However, combining the two 
proteins  yielded  strong  synergistic  effects. Together, APC-B 
and C-mDia1 produced a 3.6-fold higher actin assembly activ-
ity than the sum of their individual effects (Fig. 4 B). Consistent 
with these biochemical data, the ability of APC-B to induce   
actin assembly in NIH3T3 cells was greatly reduced after silencing 
of mDia1 expression by siRNA oligos but not control silencing 
of GAPDH (Fig. 4, C and D). Importantly, F-actin fluorescence 
intensities in cells did not differ significantly for mDia1 and 
GAPDH silencing alone (no APC injection). Together, these   
results show that APC-B and mDia1 can synergize to stimulate 
actin assembly both in a purified system and in living cells.
Based on these data, we propose the following model for 
APC-B/mDia1 synergy in assembling actin filaments (Fig. 4 E). 
APC-B dimers recruit up to four actin monomers to form a   
polymerization seed. This occurs efficiently in the presence of 
profilin. Next, mDia1 captures the barbed end of the nascent 
seed and moves processively with the growing end, accel-
erating elongation through FH1–profilin–actin interactions 
(Kovar and Pollard, 2004; Romero et al., 2004) while shielding 
growing ends from capping protein (Zigmond et al., 2003; 
Moseley et al., 2004).1093 APC protein nucleates actin assembly • Okada et al.
localization to the actin-rich cell cortex and microtubule plus 
ends (Rosin-Arbesfeld et al., 2001). The C terminus of APC, 
which includes the Basic domain, is also indispensable for di-
rectional cell motility and normal protrusive activity in cultured 
cells (Kroboth et al., 2007). These observations have suggested 
that activities inherent to the C terminus of APC make fundamental 
that loss of the C-terminal activities of APC may contribute to 
tumor progression (Samowitz et al., 1999). Indeed, one of the 
earliest defects observed in the intestinal epithelium of APC 
truncation mutant mice lacking the C terminus is aberrant cell 
architecture and cell migration (Oshima et al., 1997; Sansom   
et al., 2004). Further, the C terminus of APC is sufficient to direct 
Figure 4.  mDia1 and APC-B synergize to pro-
mote actin assembly in the combined presence 
of profilin and capping protein. (A) Reactions 
contain  2  µM  actin  monomers  (5%  pyrene 
labeled), 3 µM profilin, 2 nM CapZ, with or 
without 20 nM APC-B and/or 2 nM C-mDia1. 
(B) Quantification of elongation rates from the 
slopes of curves as in A. Rates are averages for 
reactions performed in triplicate in each of three 
separate experiments, where error bars repre-
sent standard error (n = 3). (C) Rhodamine- 
phalloidin staining of GAPDH or mDia1-depleted 
cells microinjected with EGFP-APC-B plasmid. 
Arrowheads  point  to  injected  cells.  Insets 
show GFP signal for the same area. Bar, 10 µm.   
Right  panel  is  an  immunoblot  showing  ex-
pression levels 72 h after siRNA transfection 
for  GAPDH  and  mDia1,  with  vinculin  as  a 
loading control. (D) Quantification of F-actin 
levels  induced  by  EGFP-APC-B  in  GAPDH 
or mDia1-depleted cells (n > 40). (E) Model 
for synergy between APC and mDia1 in pro-
moting actin assembly, where APC efficiently 
seeds  polymer  formation  by  recruiting  actin 
monomers from a pool of profilin-actin to form 
a prenucleation complex. The barbed end of 
the seed is captured by the FH2 domain of   
mDia1, which processively moves with the 
growing barbed end, protecting it from capping 
proteins while accelerating elongation through 
FH1–profilin–actin interactions.JCB • VOLUME 189 • NUMBER 7 • 2010   1094
purified  as  described  previously  (Soeno  et  al.,  1998;  Moseley  et  al., 
2004). Rabbit skeletal muscle actin (RMA) was purified as described previ-
ously (Spudich and Watt, 1971) and gel filtered. For fluorometric assays, 
RMA was labeled with pyrenyl iodoacetamide (Cooper et al., 1983), and for 
TIRF analysis RMA was labeled on lysines with Alexa 532–succinimidyl-ester 
(Kellogg et al., 1988). Unlabeled tubulin was purified from bovine brain 
as described previously (Goode et al., 1999).
Actin assembly and disassembly assays
Gel-filtered Ca
2+-ATP actin monomers (5% pyrene labeled) in G-buffer (3 mM 
Tris, 0.1 mM CaCl2, 0.2 mM DTT, and 0.2 mM ATP, pH 7.5) were con-
verted to Mg
2+-ATP actin by adding 0.1 vol of 10 mM EGTA and 1 mM 
MgCl2 and incubating for 2 min on ice. The actin was mixed with other 
proteins or control buffer, and polymerization was initiated by addition of 
0.1 vol of 10x initiation mix (500 mM KCl, 20 mM MgCl2, 10 mM EGTA, 
2 mM ATP, and 200 mM Tris-HCl, pH 8.0). Pyrene fluorescence was moni-
tored at excitation 365 nm and emission 407 nm in a fluorescence spectro-
photometer (Photon Technology International). For seeded filament elongation 
assays (Fig. 1 I), preassembled F-actin (0.66 µM in the final reaction) was 
sheared in the presence or absence of 20 nM APC-B and/or 100 nM 
CapZ, then mixed with 2 µM G-actin (5% pyrene labeled) and monitored 
for polymerization. For actin disassembly assays (Fig. 1 G), preassembled 
F-actin (2 µM final; 5% pyrene labeled) was mixed with Cof1 (125 or 300 nM), 
50 nM APC-B, or control buffer, then Vitamin-D binding protein was added 
to initiate net disassembly.
Sedimentation velocity analyses and analytical gel filtration
Sedimentation coefficients (S value) of polypeptides were determined as 
described previously using sucrose gradient fractionation (Balcer et al., 
2003). 10–50 µg of purified polypeptide was loaded on a 12.6-ml sucrose 
gradient (3–30%) and centrifuged for 18 h at 4°C in a rotor (SW40 Ti; 
Beckman Coulter) at 30,000 rpm. 400 µl fractions were harvested, and 
samples of each fraction were analyzed by immunoblotting. For gel filtra-
tion analysis, polypeptides were loaded on a Superose 6 column (AP Bio-
technology). Elution peaks were monitored by absorbance at 280 nm and 
verified by immunoblotting column fractions. Size standards in both analy-
ses were: aldolase (158 kD), albumin (67 kD), focal adhesion kinase FERM 
fragment (46 kD), and chymotrypsinogen A (25 kD). Native molecular 
weight was calculated from the sedimentation coefficient and Stokes radius 
as described previously (Schuyler and Pellman, 2002).
G-actin–binding analysis
For native PAGE assays, 3 µl (0.5 µg) of Ca-ATP–G-actin preincubated   
with latrunculin B in G-buffer was incubated for 10 min with or without 3 µl 
APC-B (0.5 µg; wild type or truncated) in storage buffer described above. 
Then 3 µl of 3x loading buffer (75 mM Tris, 0.6 M glycine, 0.6 mM ATP, 
CaCl2, 0.6 mM DTT, and 15% glycerol) was added before loading on na-
tive gel. Final reactions had 100 mM KCl and were fractionated on 7.5% 
native gels or 2.5% gels supplemented with 0.5% agarose as described 
previously (Moseley et al., 2004). For fluorescence-based assays, 100 nM 
Ca-ATP–G-actin (100% pyrene labeled) was preincubated for 5 min with 
100 nM latrunculin B in G-buffer. Then 55 µl of this mixture was added to 
5 µl of APC-B in storage buffer (0–75 nM final; see Fig. 2 F), and fluores-
cence levels were measured when reactions reached steady state.
Electron microscopy
G-actin (1.8 µM) was mixed with APC-C (50 nM) or control buffer, and actin 
polymerization was initiated by addition of initiation mix. After 30 s, samples 
were adsorbed onto carbon-coated Cu grids for 50 s and stained with 2% 
(wt/vol) uranyl acetate. Images were collected on an electron microscope 
(Morgagni 268; FEI) operating at 80 kV.
TIRF microscopy
TIRF microscopy was performed as described previously with minor modifi-
cations (Kovar et al., 2006). Glass flow cells were incubated with 100 nM 
N-ethylmaleimide (NEM)–myosin for 2–5 min, washed extensively with 1% 
BSA, and equilibrated with TIRF buffer (10 mM imidazole, pH 7.0, 50 mM 
KCl, 1 mM MgCl2, 1 mM EGTA, 50 mM DTT, 0.2 mM ATP, 50 nM CaCl2, 
15 mM glucose, 20 µg/ml catalase, 100 µg/ml glucose oxidase, and 
0.5% methylcellulose). 4 µl of Mg-ATP actin monomers (30% Alexa 532 la-
beled) was mixed with 6 µl of proteins (profilin, APC-B and/or C-mDia1; final 
concentrations in figure legend) or control buffer, and then added to 10 µl 
of 2x TIRF buffer. Final reactions contained 1 µM actin. Samples of re-
actions were transferred to a flow cell, and image acquisition was initiated 
within 2–5 min. Images were captured on a microscope (Eclipse GE2000-S; 
Nikon) equipped with an iXon EM-CCD camera (Andor Technology PLC) 
contributions  to  microtubule-  and  actin-based  cell  motility, 
leaving open the possibility that loss of such activities contrib-
utes to tumor progression. Future work that considers APC as a 
nucleator of actin assembly and a functionally synergizing bind-
ing partner of formins may help shed new light on how APC 
suppresses tumor formation.
Materials and methods
Plasmid construction
For expression of GFP-APC-B, GFP-APC-B-N4, and GFP-APC-B-N5 in 
NIH3T3 cells, coding sequences were PCR amplified from cDNA and sub-
cloned into HindIII–BamHI sites of pEGFP-C3 (Takara Bio Inc.). For expres-
sion and purification of C-mDia1 (residues 549–1255) from yeast, the 
designated coding sequences were PCR amplified from cDNA and sub-
cloned into pBG564 (URA3, 2µ, GAL1/10 promoter). APC-B and APC-C 
polypeptides were expressed in Escherichia coli using plasmids described 
previously (Moseley et al., 2007). To generate nested deletions in APC-B 
(Fig. 3 A), sequences were PCR amplified from a template plasmid and 
subcloned into EcoRI–NotI sites of the same vector. All plasmids were veri-
fied by DNA sequencing.
Cell culture and microinjection
NIH3T3 cells were grown in DME and 10% calf serum as described previ-
ously (Palazzo et al., 2001). For microinjection experiments, confluent 
monolayers of NIH3T3 cells were grown on acid-washed coverslips and 
serum starved for 48 h in DME plus 10 mM Hepes, pH 7.4. Cells were 
wounded 30 min before being microinjected in their nuclei as described 
previously (Palazzo et al., 2001) using 135 µg/ml of plasmid DNA diluted 
in ddH2O, and allowed to express for 3 h before fixation.
siRNA depletion
NIH3T3 cells were transfected with siRNA to silence GAPDH (5-AAAGUU-
GUCAUGGAUGACCTT-3) or mDia1 (5-AAGGUGAAGGAGGACCGC-
UUU-3) by using Lipofectamine RNAiMAX (Invitrogen) in accordance with   
the manufacturer’s protocol. Protein levels were analyzed 72 h after trans-
fection by immunoblotting with antibodies against GAPDH (rabbit 1:500; 
Santa Cruz Biotechnology, Inc.), mDia1 (mouse 1:500; BD), and vinculin 
(mouse 1:1,000; Sigma-Aldrich). For microinjection analysis, 24 h after 
transfection cells were serum starved for 48 h and injected with EGFP-APC-B 
cDNA, fixed, and processed for immunofluorescence as described below.
Epifluorescence microscopy and imaging analysis
Cells were fixed in 4% PFA in PBS for 15 min and permeabilized with 
0.5% Triton X-100 in PBS for 5 min. Rhodamine-phalloidin (1:200; Invitro-
gen) was used to detect F-actin. Cells were observed on a microscope   
(Optiphot; Nikon) using a 60x PlanApo objective (1.4 NA) and filter cubes 
optimized for GFP and rhodamine fluorescence. Images were captured 
with a CCD camera (MicroMAx; KAF 1400 chip; Kodak) running Meta-
Morph software (MDS Analytical Technologies). To quantify cellular F-actin 
staining, one region was drawn around the perimeter of the injected cell 
and another around the perimeter of a noninjected control cell in the same 
frame. Gray intensity average values were measured by MetaMorph soft-
ware and their ratio calculated after background subtraction using Excel 
(Microsoft). Statistical analysis of data was performed using Prism 4 (Graph-
Pad Software, Inc.). All images shown in figures were processed and as-
sembled using Photoshop (Adobe).
Protein purification
To circumvent issues of APC susceptibility to proteolytic degradation during 
its purification, we used separate affinity tags on either end (N-terminal 
GST, C-terminal 6His) and isolated APC-B and APC-C polypeptides from   
E. coli devoid of degraded products (Fig. 1 A). These proteins were puri-
fied  sequentially  on  Ni-NTA  (QIAGEN)  and  glutathione-agarose  beads 
(GE Healthcare) as described previously (Moseley et al., 2007). Glutathione-
eluted proteins were purified further by gel filtration on a Superose 6 column 
(GE Healthcare) equilibrated in 20 mM Tris-HCl, 600 mM KCl, 0.5 mM DTT, 
and 5% glycerol, pH 8.0. Peak fractions were pooled, exchanged into 
storage buffer (same as above except with 300 mM KCl), aliquoted, snap-
frozen in liquid N2, and stored at 80°C. MBP-APC-C polypeptide was 
purified on amylose resin (New England Biolabs, Inc.), then by gel filtration 
as above. C-mDia1 was purified as described previously (Moseley et al., 
2006). Human profilin and chicken CapZ were expressed in E. coli and 1095 APC protein nucleates actin assembly • Okada et al.
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